Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma.

BACKGROUND A moderate dose of radiation is the recommended treatment for solitary plasmacytoma (SP), but there is controversy over the role of surgery. Our study aimed at comparing different treatment modalities in the management of SP. MATERIALS AND METHODS Data from 38 consecutive patients with solitary plasmacytoma, including 16 with bone plasmacytoma and 22 with extramedullary plasmacytoma, were retrospectively reviewed. 15 patients received radiotherapy alone; 11 received surgery alone, and 12 received both. The median radiation dose was 50Gy. All operations were performed as radical resections. Local progression-free survival (LPFS), multiple myeloma-free survival (MMFS), progression-free survival (PFS) and overall survival (OS) were calculated and outcomes of different therapies were compared. RESULTS The median follow-up time was 55 months. 5-year LPFS, MMFS, PFS and OS were 87.0%, 80.9%, 69.8% and 87.4%, respectively. Univariate analysis revealed, compared with surgery alone, radiotherapy alone was associated with significantly higher 5-year LPFS (100% vs 69.3%, p=0.016), MMFS (100% vs 51.4%, p=0.006), PFS (100% vs 33.7%, p=0.0004) and OS (100% vs 70%, p=0.041). CONCLUSIONS Radiotherapy alone can be considered as a more effective treatment for SP over surgery. Whether a combination of radiotherapy and surgery improves outcomes requires further study.

[1]  R. de Tute,et al.  Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis. , 2014, Blood.

[2]  E. Colado,et al.  Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma. , 2014, Blood.

[3]  M. Dimopoulos,et al.  Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients , 2014, American journal of hematology.

[4]  Ya-fei Wang,et al.  Prognostic factors associated with solitary plasmacytoma , 2013 .

[5]  E. Lentsch,et al.  Epidemiologic Evidence of Superior Outcomes for Extramedullary Plasmacytoma of the Head and Neck , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  C. Suh,et al.  Radiotherapy for solitary plasmacytoma of bone and soft tissue , 2012, Annals of Hematology.

[7]  A. Zouhair,et al.  Radiation Therapy For The Solitary Plasmacytoma. , 2010, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[8]  Zhenhua Zhou,et al.  [Surgical intervention and radiotherapy outcome of solitary plasmacytoma of cervical spine]. , 2010, Zhonghua wai ke za zhi [Chinese journal of surgery].

[9]  Y. Shibamoto,et al.  Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[10]  O. Yersal,et al.  Clinical and prognostic features of plasmacytomas: A multicenter study of Turkish Oncology Group‐Sarcoma Working Party , 2008, American journal of hematology.

[11]  G. Lockwood,et al.  Solitary extramedullary plasmacytoma of the head and neck—Long‐term outcome analysis of 68 cases , 2008, Head & neck.

[12]  D. Peiffert,et al.  Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control. , 2005, International journal of radiation oncology, biology, physics.

[13]  E. Low,et al.  Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  W. Mendenhall,et al.  Solitary plasmacytoma of bone and soft tissues. , 2003, American journal of otolaryngology.

[15]  K. Harrington,et al.  Definitive radiotherapy for extramedullary plasmacytomas of the head and neck. , 2003, The British journal of radiology.

[16]  P. Strojan,et al.  Extramedullary plasmacytoma: clinical and histopathologic study. , 2002, International journal of radiation oncology, biology, physics.

[17]  M. Dimopoulos,et al.  Solitary bone plasmacytoma and extramedullary plasmacytoma , 2002, Current treatment options in oncology.

[18]  A. Bezjak,et al.  Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. , 2001, International journal of radiation oncology, biology, physics.

[19]  M. Kremer,et al.  Extramedullary plasmacytoma , 1999, Cancer.

[20]  J. Cox,et al.  Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. , 1998, International journal of radiation oncology, biology, physics.

[21]  G. Krol,et al.  Indications and results of combined anterior-posterior approaches for spine tumor surgery. , 1996, Journal of neurosurgery.

[22]  R. Marcus,et al.  Solitary plasmacytoma of bone and soft tissue. , 1996, International journal of radiation oncology, biology, physics.

[23]  T. Wasserman,et al.  Plasmacytoma. Treatment results and conversion to myeloma , 1992, Cancer.

[24]  N. Mayr,et al.  The role of radiation therapy in the treatment of solitary plasmacytomas. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  D. Bostwick,et al.  Solitary plasmacytoma of bone: treatment, progression, and survival. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Batsakis.  Plasma Cell Tumors of the Head and Neck , 1983 .

[27]  M. Knowling,et al.  Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Bataille,et al.  Solitary myeloma: Clinical and prognostic features of a review of 114 cases , 1981, Cancer.

[29]  C. C. Wang,et al.  Plasmacytoma of the upper air and food passages , 1972, Cancer.

[30]  J. Curschmann,et al.  Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. , 2006, International journal of radiation oncology, biology, physics.

[31]  K. Matsuo,et al.  Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study. , 2006, Asian Pacific journal of cancer prevention : APJCP.

[32]  N. Güler.  Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. , 2000, Cancer.

[33]  F. Sim,et al.  Solitary plasmacytoma of bone: Mayo Clinic experience. , 1989, International journal of radiation oncology, biology, physics.

[34]  J. Batsakis.  Pathology consultation. Plasma cell tumors of the head and neck. , 1983, The Annals of otology, rhinology, and laryngology.

[35]  M. Knowling,et al.  Radiotherapy of extramedullary plasmacytoma of the head and neck. , 1981, Clinical radiology.